Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | AZD1208 |
| Trade Name | |
| Synonyms | AZD-1208 |
| Drug Descriptions |
AZD1208 is a pan-PIM kinase inhibitor, which blocks PIM downstream signaling and leads to cell cycle arrest and apoptosis (PMID: 25505253, PMID: 32344898). |
| DrugClasses | PIM Inhibitor (Pan) 10 |
| CAS Registry Number | 1204144-28-4 |
| NCIT ID | C99380 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Alpelisib + AZD1208 | AZD1208 Alpelisib | 0 | 0 |
| AZD1208 | AZD1208 | 1 | 0 |
| AZD1208 + Cytarabine | AZD1208 Cytarabine | 0 | 0 |
| AZD1208 + Ibrutinib | AZD1208 Ibrutinib | 0 | 0 |
| AZD1208 + INCB054329 | AZD1208 INCB054329 | 0 | 0 |
| AZD1208 + Ruxolitinib | AZD1208 Ruxolitinib | 1 | 0 |
| AZD1208 + USP7-797 | AZD1208 USP7-797 | 0 | 0 |
| AZD1208 + Vemurafenib | AZD1208 Vemurafenib | 1 | 0 |